Skip to main content

Table 1 Baseline characteristics associated with prior TB diagnosis

From: Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database

    Univariate Multivariate
Characteristics No. patients No.(%) with prior TB OR p-value OR (95%CI) p-value
Total 3279 717 (22%)     
Sex       
Male 2307 582 (25%)     
Female 972 135 (14%) 0.48 <0.001 0.38 (0.30, 0.47) <0.001
Age (years)
< = 30 783 141 (18%)     
31~40 1481 366 (25%) 1.49 <0.001 1.39 (1.10, 1.76) 0.006
41+ 1015 210 (21%) 1.19 0.155 1.16 (0.89, 1.51) 0.261
Reported mode of infection
Heterosexual contact 2288 584 (26%)     
Homosexual contact 614 66 (11%) 0.35 <0.001 0.47 (0.34, 0.63) <0.001
Injecting drug use 132 34 (26%) 1.01 0.952 0.73 (0.47, 1.12) 0.154
Blood product 120 11 (9%) 0.29 <0.001 0.29 (0.15, 0.56) <0.001
Other/unknown 125 22 (18%) 0.62 0.049 0.60 (0.37, 0.98) 0.042
CD4 count at entry to TAHOD (cells/μL)
< = 50 241 84 (35%)     
51–100 209 78 (37%) 1.11 0.587 1.06 (0.74, 1.59) 0.780
101–200 524 142 (27%) 0.69 0.029 0.71 (0.50, 1.00) 0.054
201–300 578 121 (21%) 0.49 <0.001 0.58 (0.41, 0.83) 0.003
301+ 1487 217 (15%) 0.32 <0.001 0.42 (0.30, 0.58) <0.001
Not tested 240 75 (31%) 0.85 0.401 0.91 (0.61, 1.38) 0.665
HIV viral load at entry to TAHOD (copies/mL)
< = 399 1133 188 (17%)     
400~10,000 188 24 (13%) 0.74 0.187 0.93 (0.58, 1.50) 0.774
10,001+ 405 54 (13%) 0.77 0.123 0.92 (0.64, 1.32) 0.652
No. not tested 1553 451 (29%) 2.06 <0.001 1.36 (1.05, 1.76) 0.018
Antiretroviral treatment at entry to TAHOD
No treatment 830 117 (14%)     
On treatment 2449 600 (25%) 1.98 <0.001 1.99 (1.56, 2.56) <0.001
Country of TB burden
High 1990 547 (27%)     
Low/intermediate 1289 170 (13%) 0.40 <0.001 0.55 (0.42, 0.70) <0.001
  1. OR: odds ratio. CI: confidence intervals.